Currency

Protease and phosphatase inhibitor cocktail for general use , 50X

€ 84,00

Beyotime’s Protease and Phosphatase Inhibitor Cocktail for General Use (50X) includes individually packaged inhibitors for protease and phosphatase, respectively, which can be used for protein extraction from cells or tissues. The Protease Inhibitor Cocktail for General Use (50X) consists of 100mM AEBSF, 15μM Aprotinin, 6.5mM Bestatin, 0.7mM E64 and 0.5mM Leupeptin in high-purity DMSO. The Phosphatase Inhibitor Cocktail (50X) is composed of 250mM sodium fluoride, 50mM sodium pyrophosphate, 50mM β-glycerophosphate and 50mM sodium orthovanadate in H 2 O. This product also provides one tube of 0.05M EDTA for convenient use.

Package: 2ml

Description

Beyotime’s Protease and Phosphatase Inhibitor Cocktail for General Use (50X) includes individually packaged inhibitors for protease and phosphatase, respectively, which can be used for protein extraction from cells or tissues. The Protease Inhibitor Cocktail for General Use (50X) consists of 100mM AEBSF, 15μM Aprotinin, 6.5mM Bestatin, 0.7mM E64 and 0.5mM Leupeptin in high-purity DMSO. The Phosphatase Inhibitor Cocktail (50X) is composed of 250mM sodium fluoride, 50mM sodium pyrophosphate, 50mM β-glycerophosphate and 50mM sodium orthovanadate in H2O. This product also provides one tube of 0.05M EDTA for convenient use.

Many endogenous proteases and phosphatases are commonly present in cell or tissue extracts, which easily leads to degradation or dephosphorylation of protein samples. Therefore, adding appropriate inhibitors is generally necessary for protein extraction..

The protease and phosphatase inhibitors in this product are optimized for routine protein extraction from cells or tissues. It contains serine, cysteine and acidic protease inhibitors with broad inhibitory activity, aminopeptidase inhibitors, as well as serine/threonine, tyrosine, acidic and alkaline phosphatase inhibitors.

Different types of protein extracts contain different types of proteases. For example, there is high abundance of serine proteases in mammalian cell extracts, more serine proteases and metalloproteases inbacterial cell extract, and serine, cysteine and metalloproteases in mammalian tissue extracts. Plant extracts often contain large amounts of serine and cysteine proteases, and some contain aspartic proteases. Therefore, Beyotime developed a variety of inhibitor cocktails for the protein extraction from  different types of samples. Please refer to Table 1 in Appendix for details.

This product can effectively inhibit various proteases (e.g., serine protease, aminopeptidase, cysteine protease, threonine and aspartic protease, metalloproteinase) and phosphatases (e.g., serine/threonine, tyrosine, acidic and alkaline phosphatase) in conventional cell or tissue extracts. Among its components, AEBSF is a water-soluble irreversible inhibitor of serine protease, with an inhibition constant similar to that of PMSF and DFP. It can effectively inhibit trypsin, chymotrypsin, plasmin, kallikrein, thrombin, and other proteases. As a substitute for PMSF and DFP, AEBSF has lower toxicity, better water solubility and better aqueous stability. Aprotinin is a competitive reversible inhibitor of serine protease. Bestatin is a reversible inhibitor of aminopeptidase. E64 is an irreversible inhibitor of cysteine protease. Leupeptin is a reversible inhibitor of serine and cysteine protease. Pepstatin A is a reversible inhibitor of aspartic protease. EDTA, as a chelating agent, is a reversible inhibitor of metalloproteinase. Sodium fluoride is a reversible inhibitor of acid phosphatase. Sodium pyrophosphate is an irreversible inhibitor of serine/threonine phosphatase. β-glycerophosphate is a reversible inhibitor of serine/threonine phosphatase. Sodium orthovanadate is a reversible inhibitor of alkaline phosphatase and tyrosine phosphatase. Please refer to Table 2 in Appendix for specific information of various inhibitors.

This product is usually sufficient for preparing 100ml of lysis buffer.

Packing List:
Item Component Quantity
P1045-1 Protease Inhibitor Cocktail for General Use, 50X 2ml
P1045-2 Phosphatase Inhibitor Cocktail, 50X 2ml
P1045-3 0.05M EDTA, pH 8.0 2ml
Manual – 1 copy

 

Storage Conditions:

Store at -20℃ for up to 1 year.

Precautions:

It is recommended to store this product in aliquot. This product should be added into solutions immediately before use.

This product provides individually packaged EDTA, which can be used accordingly. For example, when used for metalloproteinase activity assays, EDTA should not be added.

Protease and phosphatase inhibitors contained in this product are harmful to human. Please take effective measures to avoid direct contact or inhalation.

This product is for R&D only. Not for drug, household, or other uses.

For your safety and health, please wear a lab coat and disposable gloves during the operation.

Additional information

Weight 1 kg
Dimensions 30 × 30 × 20 cm

Instruction

Instructions for Use:

Protease and phosphatase inhibitors provided in this product are 50X concentrated stock solutions, and should be added to lysis buffer at 1:50 before use (e.g., add 20μl of protease inhibitor cocktail and 20μl of phosphatase inhibitor cocktail to 1ml of lysis buffer). The lysis buffer containing protease and phosphatase inhibitors should be freshly prepared. If required, 0.05M EDTA can also be added to the lysis buffer at a ratio of 1:50. After preparation, protein extraction from cells or tissues should be performed immediately.

Product files

MSDS

https://scandicbiotech.com/wp-content/uploads/2026/04/P1045.pdf

References

Related papers:

1. Manli Wang, Xuelan Chen, Ping Tan, Yiyun Wang, Xiangyu Pan, Tianhai Lin, Yong Jiang, Bo Wang, Huan Xu, Yuying Wang, Yucen Yang, Jian Wang, Lei Zhao, Jiapeng Zhang, Ailing Zhong, Yiman Peng, Jiajia Du, Qi Zhang, Jianan Zheng, Jingyao Chen, Siqi Dai, Feifei Na, Zhenghao Lu, Jiaming Liu, Xiaonan Zheng, Lu Yang, Peng Zhang, Ping Han, Qiyong Gong, Qian Zhong, Kai Xiao, Hanshuo Yang, Hongxin Deng, Yinglan Zhao, Hubing Shi, Jianghong Man, Maling Gou, Chengjian Zhao, Lunzhi Dai, Zhihong Xue, Lu Chen, Yuan Wang, Musheng Zeng, Canhua Huang, Qiang Wei, Yuquan Wei, Yu Liu, Chong Chen
.
Cancer Cell. 2022 Sep 12;40(9):1044-1059.e8. doi: 10.1016/j.ccell.2022.08.010. (IF 26.602)
2. Ruirui Jia, Jiamei Lin, Jin You, Shi Li, Ge Shan, Chuan Huang
.
Nucleic Acids Res. 2022 Sep 9;50(16):9175-9189. doi: 10.1093/nar/gkac684. (IF 11.501)
3. Zhenxing Song, Jiamei Lin, Rui Su, Yu Ji, Ruirui Jia, Shi Li, Ge Shan, Chuan Huang
.
Nucleic Acids Res. 2022 Nov 11;50(20):11529-11549. doi: 10.1093/nar/gkac980. (IF 11.501)
4. Zhenghao Lu, Ailing Zhong, Hongyu Liu, Mengsha Zhang, Xuelan Chen, Xiangyu Pan, Manli Wang, Xintong Deng, Limin Gao, Linyong Zhao, Jian Wang, Yi Yang, Qi Zhang, Baohong Wu, Jianan Zheng, Yigao Wang, Xiaohai Song, Kai Liu, Weihan Zhang, Xiaolong Chen, Kun Yang, Xinzu Chen, YingLan Zhao, Chengjian Zhao, Yuan Wang, Lu Chen, Zongguang Zhou, Jiankun Hu, Yu Liu, Chong Chen
.
Cell Rep. 2022 Oct 18;41(3):111482. doi: 10.1016/j.celrep.2022.111482. (IF 8.109)
5. Xie M, Wang J, Gong W, Xu H, Pan X, Chen Y, Ru S, Wang H, Chen X, Zhao Y, Li J, Yin Q, Xia S, Zhou X, Liu X, Shao Q
.
J Autoimmun. 2019 Aug 102:96-113. (IF 6.658)
6. Yu M, Luo C, Huang X, Chen D, Li S, Qi H, Gao X
.
J Cell Physiol. 2019 May;234(5):7608-7621. (IF 5.546)
7. Yulin Huang, Jiaming Yang, Xizhe Liu, Xiaoshuai Wang, Kai Zhu, Zemin Ling, Baozhu Zeng, Ningning Chen, Shaoyu Liu, Fuxin Wei
.
Front Cell Dev Biol. 2022 Jan 17:9:837777. doi: 10.3389/fcell.2021.837777. (IF 5.201)
8. Yihan Wang, Xiang Yuan, Malik Ahsan Ali, Ziyue Qin, Yan Zhang, Changjun Zeng
.
Front Cell Dev Biol. 2022 Jan 26:9:792994. doi: 10.3389/fcell.2021.792994. (IF 5.201)
9. Zhanghan Chen, Zhipeng Qi, Dongli He, Jingyi Liu, Enpan Xu, Bing Li, Shilun Cai, Di Sun, Yirong Cheng, Qiang Shi, Yunshi Zhong
.
Front Cell Dev Biol. 2022 Feb 25:9:815895. doi: 10.3389/fcell.2021.815895. (IF 5.201)
10. Zewen Mei, Xingxi Huang, Heng Zhang, Danyi Cheng, Xin Xu, Mingyue Fang, Jutuan Hu, Yangyang Liu, Yunxiang Liang, Yuxia Mei
.
Int J Biol Macromol. 2022 Mar 31:202:375-387. doi: 10.1016/j.ijbiomac.2022.01.049. (IF 5.162)
11. Yang Chen, Linyuan Zeng, Hongzhang Zhu, Qifei Wu, Rong Liu, Qian Liang, Bin Chen, Haitao Dai, Keyu Tang, Changli Liao, Yonghui Huang, Xiyun Yan, Kelong Fan, Jin-Zhi Du, Run Lin, Jun Wang
.
Small Methods. 2023 May;7(5):e2201086. doi: 10.1002/smtd.202201086.
12. Mao M, Zheng X, Jin B, Zhang F, Zhu L, Cui L.
.
Exp Ther Med. 2017 Dec;14(6):5557-5563. (IF 1.785)
13. Liu D, Wu M, Li L, Gao X, Yang B, Mei S, Fu L, Mei C.
.
BRIT J NUTR. 2018 Jan;119(1):22-29. (IF 3.334)
14. Li D, Ji H, Zhao B, Xu C, Xia W, Han L, Yu D, Ju Y, Jin C
.
Mol Med Rep. 2018 Jan;17(1):1717-1723. (IF 2.1)
15. Ruifan Wu, Yongxi Yao, Qin Jiang, Min Cai, Qing Liu, Yizhen Wang, Xinxia Wang
.
INT J OBESITY. 2018 Jul;42(7):1378-1388. doi: 10.1038/s41366-018-0082-5. (IF 4.419)
16. Tang C, Gu Y, Wang H, Wu H, Wang Y, Meng Y, Han Z, Gu Y, Ma W, Jiang Z, Song Y, Na M, Lu D, Lin Z
.
Epilepsy Res. 2018 Aug;144:34-42. (IF 2.208)
17. Zhang Y, Wan J, Liu S, Hua T, Sun Q
.
Life Sci. 2018 Aug 15;207:23-29. (IF 3.647)
18. Wu R, Liu Y, Yao Y, Zhao Y, Bi Z, Jiang Q, Liu Q, Cai M, Wang F, Wang Y, Wang X
.
BBA-MOL CELL BIOL L. 2018 Oct;1863(10):1323-1330. (IF 4.519)
19. Zhao MJ, Chen SY, Qu XY, Abdul-Fattah B, Lai T, Xie M, Wu SD, Zhou YW, Huang CZ
.
Curr Med Sci. 2018 Oct;38(5):894-902. (IF 1.273)
20. He Z, Jia M, Yu Y, Yuan C, Wang J
.
BIOCHEM BIOPH RES CO. 2018 Nov 17;506(1):94-101. (IF 2.985)
21. Wu G, Jiang C, Zhang T
.
ECOTOX ENVIRON SAFE. 2018 Nov 30;164:140-148. (IF 4.872)
22. Zhang J, Li X, Wei J, Chen H, Lu Y, Li L, Han L, Lu C
.
Int Immunopharmacol. 2018 Dec;65:84-95. (IF 3.943)
25. Hu W, Wen L, Cao F, Wang Y
.
Curr Alzheimer Res. 2019 16(2):135-145. (IF 3.047)
26. Zhang B, Zhang X, Jin M, Hu L, Zang M, Qiu W, Wang S, Liu B, Liu S, Guo D
.
Mol Med Rep. 2019 Jan 19(1):309-319. (IF 2.1)
27. Fu Y, Tang M, Xiang X, Liu K, Xu X
.
Exp Ther Med. 2019 Jan 17(1):273-283. (IF 1.785)
28. Li W, Wang W, Liu L, Qu R, Chen X, Qiu C, Li J, Hayball J, Liu L, Chen J, Wang X, Pan X, Zhao Y
.
FASEB J. 2019 Mar 33(3):3317-3329. (IF 4.966)
29. Gao C, Yuan X, Jiang Z, Gan D, Ding L, Sun Y, Zhou J, Xu L, Liu Y, Wang G
.
BREAST CANCER RES TR. 2019 Jul 176(2):291-301. (IF 3.831)
31. Jia R, Jia N, Yang F, Liu Z, Li R, Jiang Y, Zhao J, Wang L, Zhang S, Zhang Z, Zhang H, Wu S, Gao F, Jiang W
.
Cell Mol Neurobiol. 2019 Aug 39(6):857-869. (IF 3.606)
33. Wang Q, Xu J, Chen Y, Liu L
.
Exp Ther Med. 2019 Nov 18(5):3493-3501. (IF 1.785)
34. Wang Y, Zhu L, Tang X, Xu H, Bao Y
.
INT J CLIN EXP PATHO. 2019 Nov 1 12(11):4214-4221. eCollection 2019. (IF 0.252)
35. Han Li, Jun-Xian Xu, Tiao-Chun Cheng, Li-Jun Tian, Jin-Feng Lin, Xi Luo, Zhao-Lian Bian, Xu-Dong Han
.
Kidney Blood Press Res. 2022;47(10):616-630. doi: 10.1159/000526916.
36. Dingchao Xia, Dazhi Chen, Tingchen Cai, Lujian Zhu, Yanhan Lin, Sijie Yu, Kailu Zhu, Xiaodong Wang, Lanman Xu, Yongping Chen
.
Toxicol Appl Pharmacol. 2022 Jan 1:434:115795. doi: 10.1016/j.taap.2021.115795.
37. Yuan-Yang Tan, Hui-Qin Zhou, Yu-Jing Lin, Liu-Tong Yi, Zhuang-Gui Chen, Qing-Dong Cao, Yan-Rong Guo, Zhao-Ni Wang, Shou-Deng Chen, Yang Li, De-Yun Wang, Yong-Kang Qiao, Yan Yan
.
Mil Med Res. 2022 Jan 29;9(1):7. doi: 10.1186/s40779-022-00366-3.
38. Hui-Qi Wang, Kai-Yi Song, Jin-Zhou Feng, Si-Yuan Huang, Xiu-Ming Guo, Lei Zhang, Gang Zhang, Ying-Chao Huo, Rong-Rong Zhang, Yue Ma, Qing-Zhe Hu, Xin-Yue Qin
.
J Mol Neurosci. 2022 Jan;72(1):97-112. doi: 10.1007/s12031-021-01894-8. (IF 2.678)
39. Nayoung Ha, Jian Sun, Qian Bian, Dandan Wu, Xudong Wang
.
Front Physiol. 2022 Feb 15:13:819619. doi: 10.3389/fphys.2022.819619. (IF 3.367)
40. Jingwen Chen, Xin Wu, Yanyi Wang, Yunfeng Pan, Yan Ren, Yusaku Nakabeppu, Yimei Fan, Yaping Wang
.
Free Radic Res. 2022 Feb;56(2):129-142. doi: 10.1080/10715762.2022.2036336.
41. Yiliang Wang, Weisheng Luo, Xiaohui Wang, Yuying Ma, Lianzhou Huang, Yifei Wang
.
J Infect. 2022 Feb;84(2):187-204. doi: 10.1016/j.jinf.2021.12.004.
42. Xing Wei, Andrew Chia Hao Chang, Haishuang Chang, Shan Xu, Yilin Xue, Yuanxin Zhang, Ming Lei, Alex Chia Yu Chang, Qingyong Zhang
.
Front Cardiovasc Med. 2022 Mar 16:9:800185. doi: 10.3389/fcvm.2022.800185.
43. Yufei Huang, Xiaoya Chu, Yafei Zhang, Sheng Yang, Yonghong Shi, Qiusheng Chen
.
Microsc Microanal. 2022 Mar 23:1-11. doi: 10.1017/S1431927622000484. (IF 3.414)
44. Yu Feng, Yintu Bao, Jiaxing Ding, Huili Li, Wei Liu, Xuehua Wang, Hongquan Guan, Zhijian Chen
.
Bioengineered. 2022 Mar;13(3):5779-5791. doi: 10.1080/21655979.2022.2033380. (IF 2.205)
45. Yuting Zhu, Shanhao Han, Jianhui Li, Hongwei Gao, Bo Dong
.
Mar Drugs. 2022 Apr 23;20(5):284. doi: 10.3390/md20050284. (IF 4.073)
46. Yue Gao, Nan Chen, Xiangle Zhang, Emma Y Li, Wei Luo, Jie Zhang, Wenqiang Zhang, Sheng Li, Jian Wang, Suning Liu
.
Front Physiol. 2022 Apr 27:13:872889. doi: 10.3389/fphys.2022.872889. (IF 3.367)
47. Tingting Bu, Ling Zhang, Ling Liu, Songfeng Yu, Jiexia Zheng, Jianping Wu, Kai Yang
.
Food Funct. 2022 Apr 4;13(7):3957-3967. doi: 10.1039/d1fo04030h. (IF 4.171)
48. Lili Li, Qin Wang, Yinghao He, Liangjie Sun, Yan Yang, Xiaonan Pang
.
Naunyn Schmiedebergs Arch Pharmacol. 2022 Apr;395(4):397-405. doi: 10.1007/s00210-021-02199-8.
49. Fangshen Guo, Yanqiang Geng, Waseem Abbas, Wenrui Zhen, Shuiqing Wang, Yuechuan Huang, Yuming Guo, Qiugang Ma, Zhong Wang
.
Front Nutr. 2022 May 10:9:888580. doi: 10.3389/fnut.2022.888580.
50. Ming Xin, Qi Gao, Xindong Xiang, Juanjuan Xu, Yuhan Jiao, Xuan Li, Xianzhen Zhang, Xiuqin Jia
.
Front Pharmacol. 2022 May 3:13:890974. doi: 10.3389/fphar.2022.890974. (IF 4.225)
51. Wei Zhang, Ling Wang, Dan Li, Douglas H Campbell, Bradley J Walsh, Nicolle H Packer, Qing Dong, Erkang Wang, Yuling Wang
.
Anal Methods. 2022 Jun 16;14(23):2255-2265. doi: 10.1039/d2ay00536k.
52. Cai Qing, Liu Ziyun, Yu Xuefei, Zhao Xinyi, Xue Xindong, Fu Jianhua
.
Inflammation. 2022 Jun;45(3):1224-1238. doi: 10.1007/s10753-021-01616-7. (IF 3.212)
53. Ruoqin Wang, Jiayu Wang, Yanjun Chen, Yuqi Chen, Qinhua Xi, Linqing Sun, Xueguang Zhang, Guangbo Zhang, Xianglin Ding, Tongguo Shi, Weichang Chen
.
Cell Death Discov. 2022 Jul 11;8(1):314. doi: 10.1038/s41420-022-01110-5.
54. Yinci Zhang, Jiaojiao Liang, Niandie Cao, Jiafeng Gao, Yinghai Xie, Shuping Zhou, Xiaolong Tang
.
BMC Cancer. 2022 Jul 16;22(1):778. doi: 10.1186/s12885-022-09874-w. (IF 3.15)
55. Yin Tang, Ke Wei, Ling Liu, Jingyue Ma, Siqi Wu, Wenjing Tang
.
PPAR Res. 2022 Sep 28:2022:7888937. doi: 10.1155/2022/7888937. (IF 2.953)
56. Jing-Ze Yu, Jing Wen, Yi Ying, Wen Yin, Si-Qi Zhang, Wen-Ling Pang, Cui Wang, Yao Bian, Jia-Li Yuan, Jin-Yuan Yan, Zhong-Shan Yang
.
Biomed Pharmacother. 2022 Oct:154:113603. doi: 10.1016/j.biopha.2022.113603. (IF 4.545)
57. Jie Zhang, Yumei Yan, Fang Cheng, Feixiang Huang, Xingliang Xie, Yanmei Sheng
.
J Vis Exp. 2022 Nov 18:(189). doi: 10.3791/64721.
58. Yangjun Yang, Xi Li, Zonghan Liu, Xinyu Ruan, Huihui Wang, Qiang Zhang, Lu Cao, Luchen Song, Yinghong Chen, Yi Sun
.
Nutrients. 2022 Nov 20;14(22):4910. doi: 10.3390/nu14224910. (IF 4.546)
59. Chan Li, Zhaoya Liu, Mengshi Chen, Liyang Zhang, Ruizheng Shi, Hua Zhong
.
Biology (Basel). 2022 Dec 26;12(1):42. doi: 10.3390/biology12010042.
60. Jing Fang, Qiang Ji, Siqi Gao, Zhun Xiao, Wei Liu, Yonghong Hu, Ying Lv, Gaofeng Chen, Yongping Mu, Hong Cai, Jiamei Chen, Ping Liu
.
Heliyon. 2022 Dec 30;9(1):e12715. doi: 10.1016/j.heliyon.2022.e12715.
61. Zhiqiang Zhang, Lei Chen, Xueheng Chen, Yiran Qin, Chao Tian, Xuening Dai, Runqi Meng, Yuanyuan Zhong, Wenyan Liang, Cheng Shen, Jinguo Zhang, Bin Zhang, Xiqing Wei
.
Biochem Biophys Res Commun. 2022 Dec 3:632:195-203. doi: 10.1016/j.bbrc.2022.10.001.
62. Mei-Yu Shen, Xiang Wang, Yu-Xi Di, Ming-Fei Zhang, Feng-Xiang Tian, Fei-Ya Qian, Bao-Ping Jiang, Ling-Ling Zhou
.
Immunopharmacol Immunotoxicol. 2022 Dec;44(6):838-849. doi: 10.1080/08923973.2022.2086139.
63. Lulu Wang, Meng Guo, Li Gao, Kai Liu, Jiawei Bai, Zhiguo Liu
.
Curr Pharm Des. 2023;29(37):2977-2987. doi: 10.2174/0113816128261624231030110157.
64. Dan Li, Guangli Feng, Yue Li, Han Pan, Pei Luo, Bo Liu, Tao Ding, Xin Wang, Huibo Xu, Yufeng Zhao, Chenhong Zhang
.
Front Endocrinol (Lausanne). 2023 Jan 18:14:1120221. doi: 10.3389/fendo.2023.1120221.
65. Yi Zhang, Shaoqing Xu, Yiwei Qian, Chengjun Mo, Penghui Ai, Xiaodong Yang, Qin Xiao
.
Front Aging Neurosci. 2023 Jan 25:15:1099018. doi: 10.3389/fnagi.2023.1099018.
66. Shi-Ying Li, Chuan-Jian Shi, Wei-Ming Fu, Jin-Fang Zhang
.
J Pharm Pharmacol. 2023 Jan 31;75(1):129-138. doi: 10.1093/jpp/rgac067.
67. Mingqian Xu, Liang Zhang, Jinfu Feng, Shuaibing Yang, Yixuan Wang, Yuyi Wang, Meiyang Chen, Li Zhou, Junjie Zhang, Qingsong Qin
.
J Med Virol. 2023 Jan;95(1):e28387. doi: 10.1002/jmv.28387.
68. Panshi Jin, Qiao Pan, Yize Lin, Yunqing Dong, Jie Zhu, Tao Liu, Weidong Zhu, Biao Cheng
.
Oxid Med Cell Longev. 2023 Feb 20:2023:2345279. doi: 10.1155/2023/2345279.
69. Siyu Gu, Yue Hou, Katarina Dovat, Sinisa Dovat, Chunhua Song, Zheng Ge
.
Exp Hematol Oncol. 2023 Feb 27;12(1):23. doi: 10.1186/s40164-023-00383-5.
70. Yunshang Yang, Dong Sheng, Jiandong Shi, Long Xiao, Zhifang Wang, Zhengyu Yin, Qi Zhuang, Shuangshuang Chen, Yajun Li, Yong Gu, Jie Zhu, Dechun Geng, Zhirong Wang
.
Biomed Pharmacother. 2023 Feb:158:114113. doi: 10.1016/j.biopha.2022.114113.
71. Xiaoli Wei, Fan Yin, Miaomiao Wu, Qianqian Xie, Xueqin Zhao, Cheng Zhu, Ruiqian Xie, Chongqing Chen, Menghua Liu, Xueying Wang, Ruixue Ren, Guijie Kang, Chenwen Zhu, Jingjing Cong, Hua Wang, Xuefu Wang
.
Acta Pharm Sin B. 2023 Mar;13(3):1128-1144. doi: 10.1016/j.apsb.2022.10.011.
72. Yingchao Wu, Dajin Pi, Shuyao Zhou, Zhongjia Yi, Yangyang Dong, Wuhong Wang, Huan Ye, Yiliu Chen, Qian Zuo, Mingzi Ouyang
.
Acta Biochim Biophys Sin (Shanghai). 2023 Apr 19;55(4):587-600. doi: 10.3724/abbs.2023068.
73. Li-Ming Zhou, Jin-Hua Fan, Min-Min Xu, Meng-Yuan Xiong, Qiao-Jiao Wang, Xue Chai, Xiao-Duo Li, Xue-Gang Li, Xiao-Li Ye
.
Biochim Biophys Acta Mol Basis Dis. 2023 Apr;1869(4):166639. doi: 10.1016/j.bbadis.2023.166639.
74. Xuefeng Zhang, Zhikun Wang, Binbin Wang, Jingyi Li, Hui Yuan
.
Open Med (Wars). 2023 Jun 12;18(1):20230721. doi: 10.1515/med-2023-0721.
75. Xiangpeng Wang, Yurong Song, Liuchunyang Yu, Xiaoxia Xue, Mingshi Pang, Yang Li, Xinyi Luo, Zhenglai Hua, Cheng Lu, Aiping Lu, Yuanyan Liu
.
ACS Appl Mater Interfaces. 2023 Jul 26;15(29):34360-34377. doi: 10.1021/acsami.3c03233.
76. Wei Jiang, Zhiwei Yang, Pu Chen, Man Zhao, Yubo Wang, Jingyuan Wang, Xinru Li, Meichen Wang, Peng Hou
.
Expert Opin Ther Targets. 2023 Jul-Dec;27(9):879-895. doi: 10.1080/14728222.2023.2259097.
77. Yue Chen, Jiagui Huang, Jie Liu, Huimin Zhu, Xuemei Li, Jun Wen, Mingfen Tian, Jiangxia Ren, Li Zhou, Qin Yang
.
Mol Neurobiol. 2023 Aug;60(8):4795-4810. doi: 10.1007/s12035-023-03378-9. (IF 4.5)
78. Mingqian Xu, Jiarui Lin, Shuaibing Yang, Jiahu Yao, Meiyang Chen, Jinfu Feng, Liang Zhang, Li Zhou, Junjie Zhang, Qingsong Qin
.
J Virol. 2023 Sep 28;97(9):e0088123. doi: 10.1128/jvi.00881-23.
79. Zhouxiang Liao, Qi Zhang, Lichao Yang, Hui Li, Wanling Mo, Zhenyu Song, Xuejing Huang, Sha Wen, Xiaojing Cheng, Min He
.
Cancers (Basel). 2023 Dec 27;16(1):129. doi: 10.3390/cancers16010129.
80. Bohao Chen, Qi He, Chuyi Chen, Yuewei Lin, Jiacong Xiao, Zhaofeng Pan, Miao Li, Shaocong Li, Junzheng Yang, FanChen Wang, Jiaxu Zeng, Yanzi Yi, Weijin Chi, Kai Meng, Haibin Wang, Peng Chen
.
Biomed Pharmacother. 2023 Dec:168:115751. doi: 10.1016/j.biopha.2023.115751.
81. Wenjun Yu, Haixia Xu, Zhe Sun, Yuxin Du, Shiqun Sun, Miyesaier Abudureyimu, Mengjiao Zhang, Jun Tao, Junbo Ge, Jun Ren, Yingmei Zhang
.
Acta Pharm Sin B. 2023 Dec;13(12):4823-4839. doi: 10.1016/j.apsb.2023.09.008.
82. Wei Yu, Jinqi Guo, Lei Mao, Qingzhu Wang, Yuanyuan Liu, Dong Xu, Jiage Ma, Chaochao Luo
.
Anim Biotechnol. 2023 Dec;34(8):3808-3818. doi: 10.1080/10495398.2023.2228847.
83. Jiapeng Ye, Zhen Hua, Jirimutu Xiao, Yang Shao, Shaoshuo Li, Heng Yin, Mao Wu, Yi Rong, Bowen Hong, Yang Guo, Yong Ma, Jianwei Wang
.
Mol Biol Rep. 2024 Apr 17;51(1):525. doi: 10.1007/s11033-024-09400-0.

Related products

  • Actin Mouse Monoclonal Antibody

    This product is a β-actin mouse monoclonal antibody prepared using a synthetic peptide of N-terminal β-actin as antigen. The clone number is AC-74. This Actin antibody recognizes only β-actin in Western blot or immunostaining analysis. Package: 40T

  • Actin-Tracker Red-555

    Actin-Tracker Red-555 is a red fluorescent probe that specifically binds and labels filamentous actin (F-actin) in cultured cells or tissue sections. Package: 0.2ml

  • Akt Rabbit Polyclonal Antibody

    This product is a high-purity polyclonal antibody obtained by immunizing rabbit with a synthetic mouse Akt C-terminal segment with appropriate modifications and then purified in two steps using protein A and antigen peptide affinity chromatography. Package:10T, 10ul

  • Alexa Fluor 488-labeled Goat Anti-Mouse IgG(H+L)

    AF488-labeled Goat Anti-Mouse IgG (H+L) is a secondary antibody for immunofluorescence staining. Package: 100ul

  • Alexa Fluor 488-labeled Goat Anti-Rabbit IgG(H+L)

    AF488-labeled Goat Anti-Rabbit IgG (H+L) is a secondary antibody for immunofluorescence staining. Alexa Fluor (AF) dyes, trademarked by Molecular Probes, are advanced fluorescent dyes derived from Coumarin, Rhodamine, Xanthene, and Cyanine via sulfonation and chemical modification (e.g., Alexa Fluor 488, or AF488). Package: 100ul

Please enter your email address to receive your cart as a PDF.